CAS
EXAS

Coppell Advisory Solutions’s Exact Sciences EXAS Stock Holding History

Coppell Advisory Solutions’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-309
Closed -$17.4K – 820
2024
Q4 		$17.4K Hold
309
– – ﹤0.01% 926
2024
Q3 		$20.4K Hold
309
– – ﹤0.01% 873
2024
Q2 		$13.1K Buy
+309
New +$17K ﹤0.01% 937
2023
Q4 		$45.8K Buy
619
+599
+2,995% +$39.3K 0.01% 515
2023
Q3 		$990 Sell
20
-465
-96% -$39.5K ﹤0.01% 939
2023
Q2 		$45.7K Buy
+485
New +$37.8K 0.01% 405
2023
Q1 		– Sell
-20
Closed -$990 – 485
2022
Q4 		$990 Buy
+20
New +$817 ﹤0.01% 940

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Coppell Advisory Solutions's EXAS Position: Q1 2025 in Review

Coppell Advisory Solutions sold out of Exact Sciences (EXAS) in Q1 2025, closing a stake of 309 shares — an estimated $17.4K sold.

Coppell Advisory Solutions first reported a position in EXAS in Q4 2022 and held it in 7 quarters. The position peaked at $45.8K in Q4 2023. 557 funds tracked by Wall St. Rank hold EXAS as of Q1 2025.

  • Coppell Advisory Solutions reported no remaining Exact Sciences position as of Q1 2025 after selling out during the quarter.
  • Coppell Advisory Solutions sold 309 Exact Sciences shares in Q1 2025, an estimated $17.4K.
  • Coppell Advisory Solutions first reported a position in Exact Sciences in Q4 2022 and held it in 7 quarters.
  • Coppell Advisory Solutions's Exact Sciences position peaked at $45.8K in Q4 2023.
  • 557 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2025.

Based on Coppell Advisory Solutions's 13F filing for Q1 2025, filed 16 May 2025.